Publication: Hormone therapy with estrogens and gestagens in peri- and post-menopause
| dc.bibliographiccitation.firstpage | 553 | |
| dc.bibliographiccitation.issue | 5 | |
| dc.bibliographiccitation.journal | Der Internist | |
| dc.bibliographiccitation.lastpage | 558 | |
| dc.bibliographiccitation.volume | 49 | |
| dc.contributor.author | Emons, G. | |
| dc.date.accessioned | 2018-11-07T11:15:34Z | |
| dc.date.available | 2018-11-07T11:15:34Z | |
| dc.date.issued | 2008 | |
| dc.description.abstract | Hormone therapy with estrogens (combined with progestin for women who have not been hysterectomized) is the most efficacious treatment for climacteric symptoms. A few years ago hormone therapy was considered to be an ideal prevention for cardio-vascular disease, osteoporosis, dementia and other diseases. Large prospective randomized trials have changed this paradigm. Hormone therapy should only be used with a clear indication (moderate to severe climacteric symptoms and - with limitations - prevention of osteoporosis). The lowest effective dose should be used for the shortest possible time. | |
| dc.identifier.doi | 10.1007/s00108-008-2107-y | |
| dc.identifier.isi | 000255627000005 | |
| dc.identifier.pmid | 18345528 | |
| dc.identifier.uri | https://resolver.sub.uni-goettingen.de/purl?gro-2/54394 | |
| dc.notes.status | zu prüfen | |
| dc.notes.submitter | Najko | |
| dc.publisher | Springer | |
| dc.relation.issn | 0020-9554 | |
| dc.title | Hormone therapy with estrogens and gestagens in peri- and post-menopause | |
| dc.type | journal_article | |
| dc.type.internalPublication | yes | |
| dc.type.peerReviewed | yes | |
| dc.type.status | published | |
| dspace.entity.type | Publication |